Top Markets
#1 Black Phoenix Black Phoenix +354.01%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +73.69%
#4 Gold Park Gold Park +58.04%
#5 Acurast Acurast +39.30%
#6 OpenEden OpenEden +38.21%
#7 BasedHype BasedHype +27.22%
#8 Cryptopia Cryptopia +21.54%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.45%
#10 Avantis Avantis +17.36%
Coin of the day
Black Phoenix Black Phoenix
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Gelesis Holdings, Inc. Gelesis Holdings, Inc.

Gelesis Holdings, Inc.

GLS
Rangering i aksjer #40695
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
Aksjekurs
$0.0121
Sist synkronisert: 2023-05-23
Markedsverdi
$97.54K
Endring (1 dag)
-24.38%
Endring (1 år)
0.00%
Land
US
Handel Gelesis Holdings, Inc. (GLS)

Kategori

Healthcare
Inntekter for Gelesis Holdings, Inc. (GLS)
Inntekter i 2026 TTM: 0
Ifølge Gelesis Holdings, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Gelesis Holdings, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE